Asianet NewsableAsianet Newsable
45 results for "

Emergency Use

"
India to become global hub for production of COVID-19 antiviral generic drugs: Fitch-dnmIndia to become global hub for production of COVID-19 antiviral generic drugs: Fitch-dnm

India to become global hub for production of COVID-19 antiviral generic drugs: Fitch

Big pharmaceutical companies in the country like Cipla Ltd, Sun Pharmaceutical Industries Ltd and Dr Reddy’s Laboratories are set to release molnupiravir capsules in the coming weeks following Indian drug regulator’s emergency use approval, Fitch added.

Business Jan 7, 2022, 5:09 PM IST

Bharat Biotech's COVID-19 vaccine Covaxin's shelf life extension up to 12 months approved by CDSCO-dnmBharat Biotech's COVID-19 vaccine Covaxin's shelf life extension up to 12 months approved by CDSCO-dnm

Bharat Biotech's COVID-19 vaccine Covaxin’s shelf life extension up to 12 months approved by CDSCO

Covaxin is approved for use under the 28-day multi-dose vial policy from Drug Controller General of India and the WHO Emergency Use Listing (WHO EUL).
 

Top Stories Dec 20, 2021, 8:07 PM IST

WHO approves Serum Institute of India Covovax for emergency approval gcwWHO approves Serum Institute of India Covovax for emergency approval gcw

WHO approves Serum Institute of India’s Covovax for emergency use

The World Health Organization announced on Friday that the coronavirus vaccine Covovax, made in India, had received emergency authorisation.

Top Stories Dec 17, 2021, 9:00 PM IST

World Health Organisation accepts Bharat Biotech's Covaxin for emergency use gcwWorld Health Organisation accepts Bharat Biotech's Covaxin for emergency use gcw

WHO accepts Bharat Biotech's Covaxin for emergency use listing

Covaxin has shown 77.8 percent efficacy against symptomatic Covid-19 and 65.2% protection against the novel Delta variant.

Top Stories Nov 3, 2021, 5:35 PM IST

WHO advisory group on Covaxin's emergency use approval says Expect recommendation within next 24 hours gcwWHO advisory group on Covaxin's emergency use approval says Expect recommendation within next 24 hours gcw

'Expect recommendation within next 24 hours or so': WHO advisory group on Covaxin's emergency use approval

Millions of Indians have received the Bharat Biotech vaccine, yet many have been unable to travel due to the WHO's permission.

World News Oct 26, 2021, 7:00 PM IST

Extremely essential often takes longer Top WHO official on approval of emergency use of Covaxin gcwExtremely essential often takes longer Top WHO official on approval of emergency use of Covaxin gcw

'Extremely essential, often takes longer': Top WHO official on approval of emergency use of Covaxin

Dr Ryan was replying to a query about if there would be a final response on Covaxin Emergency Use Listing by October 26 at a recent virtual Q&A.

World News Oct 22, 2021, 3:58 PM IST

60 lakh doses of Zydus Cadila  COVID vaccine ready in October gcw60 lakh doses of Zydus Cadila  COVID vaccine ready in October gcw

60 lakh doses of Zydus Cadila’s COVID vaccine ready after production in October, reveals report

On August 20, Zydus Cadila's ZyCoV-D was authorised for emergency usage. The vaccine is a three-dose needle-free plasmid DNA vaccination against Covid-19.

India News Oct 13, 2021, 6:44 PM IST

Covaxin gets approval for children between 2-18 years-dnmCovaxin gets approval for children between 2-18 years-dnm

Covaxin gets approval for children between 2-18 years

The Subject Expert Committee on Covid-19 approved emergency use approval to Bharat Biotech's Covaxin for children between 2-18 years.

Top Stories Oct 12, 2021, 1:26 PM IST

US pharmaceutical giant Merck applies for emergency use authorization for first COVID-19 pill-dnmUS pharmaceutical giant Merck applies for emergency use authorization for first COVID-19 pill-dnm

US pharmaceutical giant Merck applies for emergency use authorization for first COVID-19 pill

If the US Food and Drug Administration grants Merck an EUA for the pill, it would be the first oral antiviral for Covid-19.

United States Oct 12, 2021, 9:59 AM IST

WHO to take finalise decision on Covaxin next week, examining 'additional information' gcwWHO to take finalise decision on Covaxin next week, examining 'additional information' gcw

WHO to take finalise decision on Covaxin next week, examining 'additional information'

WHO stated in a tweet, "WHO and an independent panel of experts are set to meet next week to conduct out the risk/benefit evaluation and make a final decision on whether to award Covaxin Emergency Use Listing."

Top Stories Oct 6, 2021, 9:43 AM IST

US authorises COVID booster jabs for weak immune systems gcwUS authorises COVID booster jabs for weak immune systems gcw

US authorises COVID booster jabs for those with weak immune systems to curb spread of Delta variant

As the country is struggling with the Delta variant, this authorization of emergency use for the third injection of Pfizer-BioNTech and Moderna vaccines, granted by the US Food and Drug Administration (FDA) regulator, came as a relief.

United States Aug 13, 2021, 11:50 AM IST

Johnson & Johnson gets Emergency Use Approval for its single-dose COVID-19 vaccine in India-dnmJohnson & Johnson gets Emergency Use Approval for its single-dose COVID-19 vaccine in India-dnm

Johnson & Johnson gets Emergency Use Approval for its single-dose COVID-19 vaccine in India

India has so far approved four vaccines - AstraZeneca's Covishield, Bharati Biotech's Covaxin, Russian Gamaleya Institute's Sputnik V and Moderna's vaccine.

Top Stories Aug 7, 2021, 2:23 PM IST

DCGI urges Pfizer to apply for emergency use of COVID-19 vaccine-dnmDCGI urges Pfizer to apply for emergency use of COVID-19 vaccine-dnm

DCGI urges Pfizer to apply for emergency use of COVID-19 vaccine

The Drugs Controller General of India (DCGI) has urged Pfizer twice in writing to apply for emergency use authorization for its Covid vaccine so that application is processed well in time but Pfizer has not applied for the license yet.

Top Stories Jul 6, 2021, 11:03 AM IST

Expert Advice: Are vaccines effective against Delta variant? - vpnExpert Advice: Are vaccines effective against Delta variant? - vpn

Expert Advice: Are vaccines effective against Delta variant?

WHO's Chief Scientist Dr Soumya Swaminathan clarifies that all of the WHO emergency-use listed vaccines protect against developing severe disease, hospitalization and death due to the Delta variant.

Coronavirus Jul 2, 2021, 10:45 AM IST

Zydus Cadila applies for emergency use authorisation of its COVID-19 vaccine-dnmZydus Cadila applies for emergency use authorisation of its COVID-19 vaccine-dnm

Zydus Cadila applies for emergency use authorisation of its COVID-19 vaccine

An approval for Zydus’ vaccine, ZyCoV-D, would make it the fifth vaccine authorized for use in India, after Moderna, AstraZeneca and partner Serum Institute of India’s Covishield, Bharat Biotech’s Covaxin and Sputnik V developed by Russia’s Gamaleya Institute.

Top Stories Jul 1, 2021, 9:53 AM IST